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Abstract 
Scope: Nutritional supplementation of the maternal diet can modify the cancer susceptibility 
in adult offspring. Therefore, we evaluated the effects of a fish-oil diet administered to a long-term, 
during pre-mating, gestation and lactation, in reducing cancer-cachexia damages in adult Walker-256 
tumour-bearing offspring. Methods and results: Female rats received control or fish oil diet during 
pre-mating, gestation, and lactation. After weaning, male offspring were fed the control diet until 
adulthood and distributed in (C) control adult-offspring; (W) adult tumour-bearing offspring; (OC) 
adult-offspring of maternal fish oil diet; (WOC) adult tumour-bearing offspring of maternal fish oil 
diet groups. Fat body mass was preserved, muscle expression of mTOR and 4E-BP1 was modified, 
being associated with lower 20S proteasome protein expression, and the liver ALT enzyme content 
maintained in the WOC group. Also, the OC group showed reduced triglyceridemia. Conclusion: In 
this experimental model of cachexia, the long-term maternal supplementation was a positive 
strategy to improve liver function and lipid metabolism, as well as to modify muscle proteins 
expression in the mTOR pathway and also reduce the 20S muscle proteasome protein, without 
altering the tumour development and muscle wasting in adult tumour-bearing offspring. 
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1. Introduction 
Cancer cachexia is a multifactorial syndrome, characterised by systemic inflammation and 
continuous fat and lean body mass wasting, especially skeletal muscle [1,2]. In this syndrome, the 
upregulated ubiquitin-proteasome pathway [3,4] associated with the downregulated mTOR pathway 
[5] leads to muscle wasting, reducing its function, which cannot be entirely reversed by conventional 
nutrition [6]. Therefore, new strategies to prevent this wasting process in cachexia condition are 
necessary. 
One of the most used nutritional supplements in cancer treatment is the omega-3 (ω-3) 
polyunsaturated fatty acid [7], by its role in modulating protein catabolism and anti-inflammatory 
properties [7–9]. Omega-3 attenuates the ubiquitin-proteasome pathway [10] and even reduces 
different types of cancer incidence in vitro and in vivo models [11]. Rich in omega-3, the cod liver oil, 
which is often used as a nutritional supplement, has preventive effects because of higher ω-3 
eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) content. Epidemiological studies with 
high fish oil consumption, rich in omega-3, showed lower colon cancer rates and decreased risk of 
prostate cancer incidence [12,13]. Also, the exposure to -3 fatty acids during the perinatal period 
influences the offspring’s metabolic development, reducing the plasma and hepatic concentration of 
esterified fatty acids, such as plasmatic triglycerides, ameliorating peripheral insulin sensibility [14,15]. 
Also, maternal -3 diet affects growth, fat mass and lipid content in foetuses [16], as the genes 
related to lipid metabolism are more susceptible to changes during gestation and lactation, 
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influencing these metabolism pathways on offspring [17]. Thus, maternal nutrition interventions alter 
the offspring health throughout life and the disease susceptibility [18–20].  
Previous studies with the same experimental tumour model and a lifelong supplementation with 
fish oil, to dams and offspring, showed that their adult Walker-256 tumour-bearing offspring 
improved survival and macrophages and lymphocytes function[21–23]. In these studies, the authors 
focused mainly on the preventive and therapeutic administration of fish oil, rich in -3, in reducing 
cachexia damages. Instead, in this study and our previous work, we focused on preventing the 
effects of cancer-induced cachexia by the maternal influence alone. Our previous study with a 
maternal fish oil diet only during pregnancy and lactation time focused on liver responses to 
cachexia development [24], showing improved cachexia indexes, liver function, and antioxidant 
response in adult tumour-bearing rat offspring. Whereas, the mother’s initial stock of body fatty acid 
is recruited during gestation and lactation for foetal development [15], the dietary fatty acid 
composition before the conception likely influences the -3 amount disposable to the offspring. In 
this way, studies are needed to relate the offspring responses to interventions also in the pre-mating 
time. Therefore, we designed a new study also to contemplate this phase and evaluated the 
responses of muscle loss to a maternal diet intervention in order to increase knowledge in this new 
investigation area.  
In this study, we hypothesised that a long-term maternal fish oil supplementation – during pre-
mating, gestation, and lactation – could preserve the offspring damages led by the cachexia 
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development. For this purpose, we evaluated the body composition, liver function, lipid serum 
parameters, and some of the proteins related to muscle protein synthesis and degradation pathways 
along with key proteins involved in tumour growth in adult tumour-bearing offspring.  
2. Experimental Section 
2.1. Animals 
Wistar adult rats were obtained from our animal facilities and kept in our Laboratory of Nutrition 
and Cancer, in individual ventilated cages, with food and water ad libitum, under controlled 
environmental conditions (temperature, 22 ± 2 ºC; light and dark, 12/12 h; humidity, 50-60%). The 
animals were monitored daily and weighed three times per week. 
2.2. Diets 
The semi-purified diets were prepared following the American Institute of Nutrition (AIN-93) [25], 
with the same amount of protein, carbohydrate, lipids, minerals, vitamins and fibre. The control diet 
(C) contained 7% soy oil, and the fish oil diet (O) contained 7% cod liver oil, corresponding to 22.84% 
of LCPUFAs ω-3, especially EPA and DHA( fish oil: 9.69 ± 0.05 % of EPA and 9.42 ± 0.15 % of DHA), as 
shown in our previous study [24].  
2.3. Experimental procedure 
The experimental procedure was in accordance with the United Kingdom Coordinating 
Committee on Cancer Research [26] approved by the Ethics Committee on Animal Experimentation of 
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the Institute of Biology at the University of Campinas (protocol number: #4464-1). The long-term 
nutritional supplementation scheme consisted of feeding the females rats (4 month-old) with C and 
O diets during 8 weeks pre-mating [27], measuring the food intake. Then, following harem method [28], 
these females were mated with same-aged males, during one week, distributed in two groups: 
Control Dams (DC), and Fish oil Dams (DO), feeding the respective diet during gestation and 
lactation, and placed individually in cages. Dams blood was collected to analyse biochemical 
parameters at the beginning of the experiment, before mating and after weaning. 
After offspring birth, the number of male and female, and pups weight were collected and then 
the litter were reduced to 8 pups per dam. After weaning, the male pups were fed C diet until 
adulthood. At 120 days-old, the offspring were redistributed according to maternal diet and tumour 
implant into the followed groups: control adult offspring (C; n = 8); adult tumour-bearing offspring 
(W; n = 7); adult offspring of maternal fish oil diet, without tumour (OC; n = 6); adult tumour-bearing 
offspring of maternal fish oil diet (WOC; n = 10).  
Food intake was measured before and during tumour development. Tumour implant consisted 
of unique subcutaneously injection of 3x106 viable Walker-256 tumour cells in the right flank [29]. 
After 21 days of tumour growth, all the animals were euthanised by decapitation and collected 
blood, liver, gastrocnemius muscle, spleen and tumour tissue and the carcasses. The schematic 
timeline is represented in Figure 1. 
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2.4. Morphometric and serum parameters 
The body composition (bone mass, lean body mass, fat mass) was assessed by dual-energy x-ray 
absorptiometry (DEXA) Discovery model (Hologic, Marlborough, MA, USA) located in the Nuclear 
Medicine Service at the State University of Campinas. Total body water content was measured by 
the difference between the dry and wet carcass weights. The carcass weight represented the whole-
body weight without liver, spleen, gastrocnemius muscle and tumour. The body weight variation was 
calculated as the ratio between carcass weight and initial body weight, as a percentage. The cachexia 
index was calculated by the following formula: [initial weight – carcass weight + tumour weight + 
control group weight gain)/(initial weight + control group weight gain)] x 100% [30].  
Serum parameters (cholesterol, triglycerides, HDL, LDL, albumin) were quantified 
spectrophotometrically using commercial kits (Bioclin, Belo Horizonte, Brazil). The liver samples 
were homogenised in phosphate-buffered saline, and the homogenate was centrifuged at 12.000 x g 
for 15min at 4 ºC, and supernatants were assessed to measure the hepatic alanine aminotransferase 
(ALT) and aspartate aminotransferase (AST) enzymes contents, using commercial kits (Bioclin, Belo 
Horizonte, Brazil). 
2.5. Western Blot Assay 
Gastrocnemius muscles samples were homogenised in buffer (10 mM EDTA, 100 mM Tris, 10 
mM sodium pyrophosphate, 100 mM sodium fluoride, 1 mM sodium orthovanadate, 2 mM 
phenylmethylsulphonyl fluoride, 0.1 mg/mL aprotinin), centrifuged at 12,000 x g, and total protein 
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content was assessed using the Lowry method [31]. Skeletal muscle proteins (60 µg) were resolved by 
SDS-PAGE on 10% or 12% gels, followed by Western blotting assay. Proteins were probed with 
primary antibodies GAPDH (SC47724) (Santa Cruz Biotechnology, Santa Cruz, CA, USA); 20S 
(PW8195), 19S (PW9265), and 11S (PW8185) (Enzo Life Sciences, Farmingdale, NY, USA); PI3K (4292), 
phosphor-PI3K (4228), Akt (4685), phospho-AktThr308 (4056), mTOR (2972), phospho-mTOR (2971), 
p70S6K (9202), phospho-p70S6KThr421/Ser424 (9204), 4E-BP1 (9452), phospho-4E-BP1Thr70 (9455) 
(Cell Signalling, Danvers, MA USA); and secondary antibodies goat anti-rabbit (7074) and horse anti-
mouse (7076) (Cell Signalling). The band images were captured (Alliance 2.7, UVITEC, Cambridge, UK) 
and quantified using the UVIband-1D (UVITEC). The protein expression was normalised using the 
GAPDH as a loading control. 
In tumour tissue, the same protocol was followed for protein quantification using the primary 
antibodies BAX (SC7480), Bcl-2 (SC7382), VEGF (SC507) (Santa Cruz Biotechnology), Cleaved Caspase-
3 (9664), P53 (2524), phospho-P53 (9284) (Cell Signalling), and e-Cadherin (07-697) (Upstate, Lake 
Placid, NY, EUA). 
2.6. Statistical Analyses 
The results are expressed as the means ± SEM, and statistical comparisons were made with two-
way ANOVA followed by the post-hoc Bonferroni test (Graph Pad Prism software, version 7.0, San 
Diego, CA, USA). For direct comparisons between two groups, the data were analysed using the non-
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parametric Mann-Whitney test. When the p-value was < 0.05, the results were considered 
significant [32]. 
3. Results 
3.1. Fish oil diet did not change maternal body composition, whereas modified the weight gain, 
food intake and reduced triglycerides levels 
During the 8 weeks of pre-mating, the fish oil diet did not change the dams food intake and body 
weight evolution, being similar between the DC and DO groups (Figure 2A and 2B).  During gestation 
until the 32nd day (which correspond to 11th lactation day), food intake was similar, but after that, 
showing an effect of the maternal diet, the DO group had a reduction compared to DC until weaning 
(Figure 2C). The DO body weight gain was also reduced on the 17th - 20th pregnancy days in relation 
to DC, followed by a recovery in both groups that lasted until weaning (Figure 2D and 2E). 
Also evaluating the dams responses to the maternal diet, the serum cholesterol, triglycerides 
and albumin levels were analysed, being similar between both groups after pre-mating (Table 1). 
After weaning, the triglycerides levels reduced in the DO group (p = 0.03), likely indicating a 
modulation by the maternal diet, with no alterations in the fat and lean body mass contents, water 
content and relative bone mass (Table 1).  
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3.2. Long-term maternal fish oil diet modified offspring growth, but not permanently 
In relation to the litters, the long-term maternal fish oil diet did not alter the number of 
pups/litter, the female/male proportion and, especially, the birth weight (Supporting Information 
Table S1). 
In accordance with the birth weight, the offspring had similar body weight in both groups on the 
second day until the 14th day after birth (Figure 3A). However, the OC pups body weight reduced 
compared to C group, which was recovered at the 44th day, then, maintaining similar until the 
tumour inoculation, at 120 days-old (Figure 3B). 
3.3. Long-term maternal fish oil diet did not prevent body wasting in adult tumour-bearing 
offspring but modified hepatic ALT levels and serum triglycerides content 
There were no significant differences in the initial body weight neither in the initial food intake 
among the groups before tumour implant (Table 2). After 21 days of tumour growth, the carcass 
weight and weight variation in tumour-bearing groups reduced when compared to non-tumour-
bearing groups (carcass weight: W < C, p = 0.0012 WOC < OC, p = 0.0063; weight variation: W < C, 
and WOC < OC, p < 0.0001, Table 2). Also as a consequence of the cachexia [2], the final food intake in 
W group was 56% lower than in C group, whereas in the WOC group the food intake reduced 43% 
compared to the OC group (W < C, p < 0.0002; WOC < OC, p = 0.0308, Table 2). 
The liver weight was similar among the groups, as well the gastrocnemius muscle weight (Table 
2), despite the decrease in the carcass weight. The increased spleen weight indicated an overload of 
www.mnf-journal.com Molecular Nutrition & Food Research 
 
This article is protected by copyright. All rights reserved. 
 
the immune response in both tumour-bearing groups (W > C, WOC > OC, p < 0.0001). The long-term 
maternal fish oil diet did not alter the tumour weights, and the cachexia indexes in W and WOC, 
being similar between the groups. 
In order to verify whether the maternal diet could influence adult offspring, we accessed the 
serum parameters and hepatic metabolism, usually deregulated in the cachexia syndrome [1] (Table 
3). The serum albumin content reduced in both tumour-bearing groups (W < C; WOC < OC, p < 
0.0001; being the tumour factor responsible for 74% of the total variation), and the total cholesterol 
levels had difference only between WOC and C groups (WOC < C, p = 0.0007) (Table 3). The LDL-C 
levels were similar among the groups. Besides, the HDL-C level reduced in both W and WOC (W < C, 
p < 0.0001; WOC < OC, p = 0.0007; as the tumour factor accounted for 62.3% of total variation, 
considered extremely significant). Showing another positive effect led by the maternal diet, the 
triglycerides levels reduced in OC compared to control group (OC < C, p = 0.0465), and W tumour-
bearing group (W > OC, p = 0.0007), showing a significant effect led by diet factor (26.8%) and by 
tumour factor (20.4%). Another effect influenced by maternal diet was related to the liver function. 
Whereas the tumour-bearing group showed an increased hepatic ALT content (where the tumour 
factor accounted for 25% of total variation, being considered very significant effect), a similar 
content of this liver enzyme occurred in both fish oil maternal supplemented groups (OC = WOC; 
Table 3). Additionally, the WOC group had lower ALT content than W group (WOC < W, p = 0.0087; 
where this effect accounted for 14% of total variance), showing another positive effect of this 
maternal intervention. On the other hand, the AST content was similar among the groups (Table 3).  
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The lean body mass decreased in both tumour groups (W < C, p = 0.0417; WOC < OC, p = 
0.0012). Additionally, the relative fat body mass reduced only in the tumour-bearing group (W < C, p 
= 0.0115) (Table 4). As a positive effect of maternal nutritional intervention, the fat body mass was 
maintained in both groups supplemented with fish oil, showing less fat mass spoliation 
independently of tumour growth. Moreover, the water body content was higher in W and WOC (W > 
C, p = 0.00168; WOC > OC, p = 0.0022).  
 
3.4. Long-term maternal fish oil diet modified the mTOR pathway and reduced the muscle 20S 
proteasome protein expression without changing tumour parameters  
The mTOR pathway is usually impaired in cachectic animals showing impairment on protein 
synthesis [33]. The activation of PI3K and Akt, upstream activators of the mTORC1 pathway, had no 
differences among the groups (Supporting Information Figure S1A and B). Moreover, the mTORC1 
activation did not show differences between both tumour-bearing groups (Figure 4A), but the 
tumour factor accounted for 59,6% of the total variation, which means that the tumour effect was 
considered extremely significant reducing the mTOR activation compared to the control groups (W < 
C, p = 0.0605; WOC < OC, p < 0.0016; Figure 4a). The activation of the downstream protein P70S6K1 
was similar among the groups (Supporting Information Figure S1C). Conversely, the 4E-BP1 
activation reduced in WOC group (WOC < OC, p = 0.0002) and the tumour factor accounted for 
52.9% of the total variation which means that the tumour effect is considered extremely significantly 
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(Figure 4b). In relation to the maternal diet effect, the muscle mTORC1 and 4EBP-1 protein content 
were higher in the OC group when compared to the W group (OC > W; p = 0.0005 and p = 0.0011; 
respectively), but the diet factor accounted for approximately 8,5% of the total variation, where the 
diet effect was considered not quite significant for this parameter.   
In relation to protein degradation, the muscle proteasome subunits were evaluated, showing 
some maternal fish oil diet effects. The 19S regulatory subunit and the 20S catalytic subunit (32KDa) 
showed no differences among the groups (Figure 4c and 4d). On the other hand, for the other 20S 
catalytic subunit (28KDa), we observed the maternal influence for both maternal supplemented 
groups. The WOC tumour-bearing group had a reduction in this 20S proteolytic subunit (28KDa) in 
comparison to the W group (WOC < W, p = 0.00117, Figure 4E), and also the OC group showed a 
reduced expression compared to the W group (OC < W, p = 0.0138, Figure 4E, the diet factor 
accounted for 56% of total variation, being extremely significant).  
In order to verify the effects of the long-term fish oil diet on tumour development, proteins 
related to cellular death (BAX, Caspase-3, Bcl-2), angiogenesis (VEGF), metastasis (e-Cadherin), and 
tumour suppression (p53) were quantified, and no differences were found between the tumour-
bearing groups W and WOC, showing no effects of this nutritional scheme, in accordance with the 
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4. Discussion 
In this study, as an innovative of maternal nutritional approach against other studies in the 
literature [21–23], we have shown that a long-term maternal fish oil diet, during the periods of pre-
mating, gestation and lactation, influenced a few parameters in adult tumour-bearing offspring. 
Although fish oil supplementation only during pregnancy and lactation, as demonstrated in our 
previous work, can decrease the cachexia impairment, reducing cachexia index and ameliorating 
liver function and reducing its oxidative stress [24], here we showed that with the additional pre-
mating diet for 8 weeks, the fish oil diet had no efficient effect in preserving the energy body sources 
of the tumour-bearing offspring. However, this maternal nutritional scheme influenced the lipid 
metabolism and modulated the expression of the mTOR and 20S proteasome protein and, similarly, 
preserved liver function in adult tumour-bearing offspring. 
In both dams groups, with the long-term fish oil supplementation, we observed that serum 
albumin and bone, fat and lean body mass were similar before and after gestation and lactation, 
probably indicating the safety of this maternal diet supplementation. Besides, as one of the benefits 
of omega-3-rich diets [34], the reduced triglyceridemia in DO group likely showed a positive effect of 
this intervention, modifying the lipid metabolism. In addition, considering that the offspring had a 
similar profile of body weight evolution, except for late weaning and three weeks after weaning, 
associated to a decrease in serum triglycerides in adulthood, as a similar pattern as observed in their 
mothers, this fact showed the maternal influence on this modulation. A study with soy oil (rich in 
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omega-6), and flaxseed oil (rich in omega-3) diets, administered on the last ten days of pregnancy 
and during breastfeeding, showed that the -3 supplemented-offspring had reduced leptin levels 
[35], which could possibly explain the offspring reduction of body weight on the 14th – 44th  day of life 
followed by recovery and the modulating effect on lipid metabolism in the adult-offspring.  
Here we verified that the cachexia state happened in both adult offspring independently of the 
maternal nutritional scheme. The low food intake and the altered serum parameters, such as serum 
albumin, triglycerides and HDL-C combined to changed body composition confirmed the cachexia 
condition in both tumour-bearing animals. The lower lean body and fat body masses, as verified in W 
group, corroborated these altered serum parameters levels, showing that the tumour growth 
induced the host energy source waste, especially over lipid and protein content, according to the 
literature [1,2]. Conversely, the maternal fish oil diet could preserve the fat body mass storage in the 
tumour-bearing offspring, likely showing an improvement of the lipid metabolism, despite not 
reflecting in an improvement of the global carcass spoliation. This is an important finding, beyond 
the muscle wasting,  one of the severe effects of cancer cachexia is the spoliation of the host adipose 
tissue [1]. Thus, this long-term maternal nutrition supplementation could reduce the cachexia impact 
by preserving this tissue so relevant to the syndrome development.   The increased water body 
content was associated with decreased serum albumin, which likely led to a reduced serum osmotic 
pressure, inducing oedema, as expected in the cachectic state [33]. Despite having a tumour, the 
tumour-bearing groups had no differences on the triglyceridemia and cholesterol levels, even with 
minimal benefit effects led by the maternal nutritional scheme. However, the fish oil diet could 
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induce changes in the triglyceridemia, with diminished content in the OC group compared with the 
control group. This could indicate another improvement of lipid metabolism by the maternal diet. 
Similar results have been observed, as Mennitti and colleagues demonstrated that 21-days old rat 
offspring from mothers under fish oil supplemented diet reduced serum triglycerides levels [14].  
Besides, regarding liver function, the WOC group had hepatic ALT levels different from W group, 
suggesting that the altered hepatic function found in W group, as a consequence of tumour damage 
effect, was improved by the influence of maternal supplementation in WOC, as indicated by the 
preserved content of this liver enzyme. These results likely suggested a modulatory effect of 
maternal diet over liver responses faced to tumour growth, in accordance with our previous work, 
showing that the additional diet intervention during pre-mating phase led to the same positive 
results found in relation to liver function [24]. 
Moreover, when evaluating the muscle protein synthesis, the mTORC1 pathway was less 
activated in both tumour-bearing groups, likely leading to lower protein synthesis. This fact is 
corroborated by the reduced lean body mass found in W group, and also in WOC group, suggesting 
that the long-term maternal supplementation was not efficient in preserving the protein synthesis. 
However, as a positive effect of maternal fish oil diet, in adult offspring without tumour, this 
maternal diet scheme could modify the mTOR and 4-EBP1 proteins, increasing their expression. 
Additionally, by the literature, the damage effects of tumour growth can upregulate some protein 
degradation pathways, especially the ubiquitin-proteasome pathway [36,37]. Here, interestingly, the 
19S, the ATP-dependent regulatory subunit, showed no differences among the groups, while the 
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expression of 20S (28KDa) catalytic subunit reduced in the maternally supplemented groups (OC and 
WOC), likely due to epigenetic modifications, downregulating this subunit expression.  Indeed, this is 
in accordance with treated cachectic mice with EPA, which had an attenuated expression of the 20S 
subunits [38], showing the same effect for the preventive approach. However, maternal 
supplementation did not prevent lean body mass waste. Thus, other protein degradation pathways 
could be driving this spoliation, as seen in previous studies with the same tumour model [39,40]. 
Moreover, it would be interesting to evaluate the proteasomal activity correlating with the 
proteasomal protein expression levels. This analysis could also be important to clarify the maternal 
influence over this degradation pathway, which is a limitation of our study.  
In addition, the omega-3 supplementation was previously reported as anticarcinogenic and with 
properties of reducing the tumour growth [11,23,41]. In a maternal preventive administration, there 
were no differences between the tumour relative weights in W and WOC groups, confirmed by the 
similar expression of proteins related to cellular death, angiogenesis, metastasis, and tumour 
suppression. These results suggest that the fish oil maternal supplementation had no effect on 
altering the epigenome of the offspring regarding the modulation of the Walker 256 tumour 
microenvironment. Therefore, in further studies, it would be interesting to use an induced tumour 
model to verify the possible intergenerational influence, observing not only the tumour 
microenvironment modulation but also the oncogenesis modulation from the host cells.  
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Summing up, the long-term maternal supplementation with fish oil improved hepatic function 
and lipid metabolism, preserving the fat body mass, modifying the expression of some proteins of 
the mTOR pathway and downregulated the expression of 20S muscle protein, related to the 
ubiquitin-proteasome pathway, in adult offspring. On the other hand, this maternal diet scheme did 
not affect tumour development and had no effect on preventing lean body mass loss. Overall, the 
long-term maternal supplementation may influence the epigenetic modifications of the offspring, 
since it possibly had modulated the maternal metabolism, PUFA sources and therefore the -3 
amount delivered to foetus and neonates, improving some essential functions in adult offspring, 
independently of the tumour presence. Thus, more studies are necessary to clarify the involved 
epigenetic modifications provided by this long-term maternal supplementation. 
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Figures and tables 
 
Figure 1: Experimental procedure scheme. DC: Control Dams fed control diet; DO: Omega -3 Dams fed fish oil 
diet; C: control adult offspring; W: adult tumour-bearing offspring; OC: adult offspring of maternal fish oil diet, 
without tumour; WOC: adult tumour-bearing offspring of maternal fish oil diet (n ≥ 6, per group). 
 
Figure 2. Food intake and body weight gain in both dam groups. (a) Food intake during the pre-mating period 
(g). (b) Body weight evolution during the pre-mating period (g). (c) Food intake during pregnancy and lactation 
periods (g). (d) Body weight gain during pregnancy (%). (e) Body weight gain during lactation (%). DC: Control 
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Dams (n = 4); DO: Fish Oil Dams (n = 6). The values are means ± SEM, and for some points, the error bars would 
be shorter than the symbol size. 
*
 Compared to DC group, p < 0.05, detected by Mann-Whitney test. 
 
Figure 3. Offspring growth evolution from birth until adulthood from both experimental diet schemes. (a) Body 
weight evolution from the 2
nd
 to the 44
th
 day old (g). Each litter was weighed and distributed by the number (n 




day-old (g). C: control offspring (n = 15); 
OC: adult offspring of maternal fish oil diet (n = 16). The values are means ± SEM, and for some points, the 
error bars would be shorter than the symbol size. 
*
 Compared to C, p < 0.05, detected by Mann-Whitney test. 
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Figure 4. mTOR pathway and proteasome subunits proteins expression in gastrocnemius muscle. (a) 
pmTOR/mTOR content; (b) p4E-BP1/4E-BP1 content; (c) 19S content; (c) 20S (32 KDa) content; (e) 20S (28KDa) 
content. The results represent the quantified and normalised bands by GAPDH expression. Western blot 
images were representative of all different groups. Values are expressed as the relative percentage of the C 
group, considered as 100%, and are presented as means ± SEM. C: control adult offspring (n = 6); W: adult 
tumour-bearing offspring (n = 6); OC: adult offspring of maternal fish oil diet (n = 6); WOC: adult tumour-
bearing offspring of maternal fish oil diet (n = 7). Significant differences detected by two-way ANOVA showed 
that: for mTOR analysis, tumour factor accounted for p < 0.0001, diet factor for p = 0.0558 and interaction 
effect for p=0.2761; for 4EBP1 analysis, tumour factor accounted for p = 0.0001, diet factor for p = 0.1128 and 
interaction effect for p = 0.0476; 19S analysis, tumour factor accounted for p = 0.792, diet factor for p = 0,0275 
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and interaction effect for p = 0.2297; 20S (32kDa), tumour factor accounted for p = 0.2063, diet factor for p = 
0.1034 and interaction factor for p = 0.0994; 20S (28kDa), tumour factor accounted for p = 0.5261, diet factor 
for p = 0.0002 and interaction effect for p = 0.2297. Differences:  
a
 Compared to C, p < 0.05; 
b
 compared to OC, 
p < 0.05, 
c
 compared to W, p < 0.05, detected by the post-hoc Bonferroni test.  
 
Table 1. Dams parameters after pre-mating and weaning. 
Dams serum parameters 
After pre-mating DC (n = 4) DO (n = 6) 
Cholesterol (mg/dL) 133.78 ± 1.89 129.79 ± 3.94 
Triglycerides (mg/dL) 109.27 ± 3.83 106.13 ± 3.81 
Albumin (g/dL) 3.20 ± 0.21 3.18 ± 0.20 
After weaning DC (n = 4) DO (n = 6) 
Cholesterol (mg/dL) 131.16 ± 5.93 125.20 ± 2.56 
Triglycerides (mg/dL) 124.10 ± 15.06 92.03 ± 2.64* 
Albumin (g/dL) 3.59 ± 0.02 3.71 ± 0.07 
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Dams Body Composition 
After weaning DC (n = 4) DO (n = 6) 
Fat Mass (%) 17.50 ± 2.59 15.93 ± 0.64 
Lean Body Mass (g) 39.78 ± 3.87 36.81 ± 1.88 
Water Content (%) 62.10 ± 1.23 63.22 ±0.61 
Bone Mass (%) 4.10 ± 0.14 3.89 ± 0.22 
Legend: DC: dams fed control diet; DO: dams fed fish oil diet. The values are means ± SEM. 
*
 Compared to DC, 
p < 0.05, detected by Mann-Whitney test. 
 





   
Parameter Group *p-value 
 

















0.8048 0.1255 0.8389 
Carcass weight 541.79 ± 448.48 ± 521.45 ± 438.70 ± 
<0.0001* 0.3467 0.7396 
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0.3812 0.0333* 0.3466 
Gastrocnemius 
(g) 
3.27 ± 0.16 3.10 ± 0.21 3.30 ± 0.15 2.85 ± 0.11 
0.0635 0.5112 0.3811 











<0.0001* 0.6752 0.6864 















- - - 
Legend: C: control adult offspring; W: adult tumour-bearing offspring; OC: adult offspring of maternal fish oil 
diet; WOC: adult tumour-bearing offspring of maternal fish oil diet. The values are means ± SEM. *Significant 
difference accounted for tumour factor, diet factor, or interaction effect, analysed by two-way analysis of 
variance (ANOVA).  
a
 Compared to C, p < 0.05; 
b
 compared to OC, p < 0.05, 
c
 compared to W, p < 0.05, detected 
by two-way ANOVA, followed by the post-hoc Bonferroni test. 
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Table 3. Adult offspring serum and hepatic parameters. 
Serum and hepatic parameters 
Parameter Group p-value 
 






Albumin (mg/dL) 3.55 ± 0.20 2.90 ± 0.13
a
 3.42 ± 0.21
 c
 2.92 ± 0.14
a,b
 <0.0001* 0.3574 0.2315 
Cholesterol 
(mg/dL) 





0.0033* 0.0296 0.5675 
HDL-C (mg/dL) 28.93 ± 3.08 12.62 ± 1.64
a







<0.0001* 0.5730 0.4923 
LDL-C (mg/dL) 2.89 ± 0.49 3.89 ± 0.57 2.34 ± 0.54 3.53 ± 0.70 0.1070 0.4971 0.8862 
Triglycerides 
(mg/dL) 





132.70 ± 7.56 
0.0048* 0.0016* 0.4857 
Hepatic AST (%) 100.00 ± 5.21 88.67 ± 3.15 92.77 ± 4.46
 
 100.60 ± 2.70 0.6658 0.5660 0.0256 












0.0023* 0.0155* 0.0404* 
Legend: C: control adult offspring; W: adult tumour-bearing offspring; OC: adult offspring of maternal fish oil 
diet; WOC: adult tumour-bearing offspring of maternal fish oil diet. The values are means ± SEM. *Significant 
difference accounted for tumour factor, diet factor, or interaction effect, analysed by two-way analysis of 
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variance (ANOVA).  
a
 Compared to C, p < 0.05; 
b
 compared to OC, p < 0.05, 
c
 compared to W, p < 0.05, detected 
by two-way ANOVA, followed by the post-hoc Bonferroni test. 
 
Table 4. Adult offspring body composition. 
Body composition 
Parameters Groups *p-value 
 

















0.0002* 0.3270 0.6967 









26.23 ± 0.96 0.0002* 0.7191 0.5116 
Water body content 
(%) 













<0.0001* 0.7500 0.5471 
Legend: C: control adult offspring; W: adult tumour-bearing offspring; OC: adult offspring of maternal fish oil 
diet; WOC: adult tumour-bearing offspring of maternal fish oil diet. The values are means ± SEM. *Significant 
difference accounted for tumour factor, diet factor, or interaction effect, analysed by two-way analysis of 
variance (ANOVA).  
a
 Compared to C, p < 0.05; 
b
 compared to OC, p < 0.05, detected by two-way ANOVA, 
followed by the post-hoc Bonferroni test. 
 
